HomeSHPHF • OTCMKTS
add
Sihuan Pharmaceutical Holdings Group Ltd
Nakaraang pagsara
$0.19
Sakop ng taon
$0.10 - $0.21
Market cap
12.53B HKD
Average na Volume
10.00
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 735.90M | 54.70% |
Gastos sa pagpapatakbo | 386.99M | -22.90% |
Net na kita | 38.55M | 142.07% |
Net profit margin | 5.24 | 127.21% |
Kita sa bawat share | — | — |
EBITDA | 185.33M | 232.48% |
Aktuwal na % ng binabayarang buwis | 54.19% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 3.98B | 9.48% |
Kabuuang asset | 11.63B | 10.45% |
Kabuuang sagutin | 4.73B | -15.24% |
Kabuuang equity | 6.90B | — |
Natitirang share | 9.04B | — |
Presyo para makapag-book | 0.29 | — |
Return on assets | 2.91% | — |
Return on capital | 4.30% | — |
Cash Flow
Net change in cash
| (CNY) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 38.55M | 142.07% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Sihuan Pharmaceutical is a Chinese pharmaceutical manufacturer with headquarters in Beijing and branch office in Haikou, Hainan Province. The main company in the group is the holding company Sihuan Pharmaceutical Holdings Group Ltd, which is listed on the Hong Kong stock market.
Sihuan Pharmaceutical is collaborating with the Academy of Military Medical Science in the development of the drug JK-05, intended for the treatment of Ebola virus disease. The company has been challenged by Fujifilm Holdings Corporation, which has stated that JK-05 infringes its patent rights regarding Avigan. Wikipedia
CEO
Itinatag
2001
Website
Mga Empleyado
2,843
